#Astral professional#
Our projects include Digital Signage used in the retail and public sectors, Professional Displays and other facilities like Room Scheduling systems for boardrooms and robust Control Systems that make the magic happen.Ĭontact us to discuss your requirements. The commercialand Corporate markets are an essential part of what we do.
With brands like Philips, Denon, Marantz, Philips Dynalite, Control4 and Bang & Olufsen (amongst others) we have the right brands and the best and most experienced installation team to make your dream Home Automation system come to life.
From our humble beginnings, providing and servicing the best high-end audio video equipment, we have over the years evolved as market leaders for our residential and commercial clients.įrom the latest TVs and soundbar systems to a state-of-the-art Home Cinema, from Lighting Control, Intruder Alarms and CCTV to Intercom Systems, we are the one stop destination for your Smart Home System. (Current Controlled Trials number, ISRCTN59586944.Astral has been present in the technology sector since 1975. We found substantial risks but no evidence of a worthwhile clinical benefit from revascularization in patients with atherosclerotic renovascular disease. Serious complications associated with revascularization occurred in 23 patients, including 2 deaths and 3 amputations of toes or limbs. The two study groups had similar rates of renal events (hazard ratio in the revascularization group, 0.97 95% CI, 0.67 to 1.40 P=0.88), major cardiovascular events (hazard ratio, 0.94 95% CI, 0.75 to 1.19 P=0.61), and death (hazard ratio, 0.90 95% CI, 0.69 to 1.18 P=0.46). There was no significant between-group difference in systolic blood pressure the decrease in diastolic blood pressure was smaller in the revascularization group than in the medical-therapy group. Over the same time, the mean serum creatinine level was 1.6 micromol per liter (95% CI, -8.4 to 5.2 ) lower in the revascularization group than in the medical-therapy group. The median follow-up was 34 months.ĭuring a 5-year period, the rate of progression of renal impairment (as shown by the slope of the reciprocal of the serum creatinine level) was -0.07x10(-3) liters per micromole per year in the revascularization group, as compared with -0.13x10(-3) liters per micromole per year in the medical-therapy group, a difference favoring revascularization of 0.06x10(-3) liters per micromole per year (95% confidence interval, -0.002 to 0.13 P=0.06). Secondary outcomes were blood pressure, the time to renal and major cardiovascular events, and mortality. The primary outcome was renal function, as measured by the reciprocal of the serum creatinine level (a measure that has a linear relationship with creatinine clearance). In a randomized, unblinded trial, we assigned 806 patients with atherosclerotic renovascular disease either to undergo revascularization in addition to receiving medical therapy or to receive medical therapy alone. Percutaneous revascularization of the renal arteries improves patency in atherosclerotic renovascular disease, yet evidence of a clinical benefit is limited. Astral Chain - Overview Trailer Learn more about the latest action game from PlatinumGames in this overview trailer highlighting combat and more.
0 kommentar(er)
